Paper41998449
Geraniol and Z-guggulsterone co-treatment attenuates Alzheimer's disease in adult zebrafish by targeting oxidative damage, neuroinflammation, mitochondrial stress, and synaptic dysfunction.
Chauhan P and 2 others. Inflammopharmacology, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Geraniol and Z-guggulsterone co-treatment attenuates Alzheimer's disease in adult zebrafish by targeting oxidative damage, neuroinflammation, mitochondrial stress, and synaptic dysfunction. Papers, record 41998449. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41998449
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Geraniol and Z-guggulsterone co-treatment attenuates Alzheimer's disease in adult zebrafish by targeting oxidative damage, neuroinflammation, mitochondrial stress, and synaptic dysfunction.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Oxidative Stress | Major topic |
| Acyclic Monoterpenes | Major topic |
| Pregnenediones | Major topic |
| Animals | |
| Zebrafish | |
| Neuroprotective Agents | |
| Disease Models, Animal | |
| Mitochondria | |
| Male | |
| Drug Therapy, Combination | |
| Inflammation |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38795639 | Geraniol mitigates anxiety-like behaviors in rats by reducing oxidative stress, repairing impaired hippocampal neurotransmission, and normalizing brain cortical-EEG wave patterns after a single electric foot-shock exposure. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38795639 | PubMed |
| 2 | 22246918 | Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump. | J Lipid Res | 2012 | https://conductscience.org/library/papers/22246918 | PubMed |
| 3 | 24422 | Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. | Arch Biochem Biophys | 1978 | https://conductscience.org/library/papers/24422 | PubMed |
| 4 | 38780722 | Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38780722 | PubMed |
| 5 | 39956886 | Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/39956886 | PubMed |
| 6 | 40972727 | Reinwardtia indica Dumort. protects against ponatinib-induced cerebral ischemia in adult zebrafish via attenuation of oxidative stress, neuroinflammation, mitochondrial dysfunction, and neurotransmitter dysregulation: A multi-target therapeutic strategy. | J Ethnopharmacol | 2026 | https://conductscience.org/library/papers/40972727 | PubMed |
| 7 | 39490623 | Zebrafish as a model organism to study sporadic Alzheimer's disease: Behavioural, biochemical and histological validation. | Exp Neurol | 2025 | https://conductscience.org/library/papers/39490623 | PubMed |
| 8 | 39736972 | Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39736972 | PubMed |
| 9 | 39800453 | Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation. | J Prev Alzheimers Dis | 2025 | https://conductscience.org/library/papers/39800453 | PubMed |
| 10 | 40375989 | Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms, and human health benefits - a comprehensive review. | Front Immunol | 2025 | https://conductscience.org/library/papers/40375989 | PubMed |
| 11 | 21620901 | ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor. | Behav Brain Res | 2011 | https://conductscience.org/library/papers/21620901 | PubMed |
| 12 | 13650640 | Tissue sulfhydryl groups. | Arch Biochem Biophys | 1959 | https://conductscience.org/library/papers/13650640 | PubMed |
| 13 | 37054939 | Geraniol improves passive avoidance memory and hippocampal synaptic plasticity deficits in a rat model of Alzheimer's disease. | Eur J Pharmacol | 2023 | https://conductscience.org/library/papers/37054939 | PubMed |
| 14 | 40201829 | The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model. | Open Vet J | 2025 | https://conductscience.org/library/papers/40201829 | PubMed |
| 15 | 37203336 | Insulin resistance, cognition, and Alzheimer disease. | Obesity (Silver Spring) | 2023 | https://conductscience.org/library/papers/37203336 | PubMed |
| 16 | 33129097 | Z-Guggulsterone alleviated oxidative stress and inflammation through inhibiting the TXNIP/NLRP3 axis in ischemic stroke. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/33129097 | PubMed |
| 17 | 23150171 | A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). | Mol Neurobiol | 2013 | https://conductscience.org/library/papers/23150171 | PubMed |
| 18 | 40253240 | Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force. | J Prev Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40253240 | PubMed |
| 19 | 40660381 | Pathological mechanisms and treatment progression of Alzheimer's disease. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40660381 | PubMed |
| 20 | 30168601 | Z-Guggulsterone attenuates astrocytes-mediated neuroinflammation after ischemia by inhibiting toll-like receptor 4 pathway. | J Neurochem | 2018 | https://conductscience.org/library/papers/30168601 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41998449
GET https://conductscience.org/api/papers/v1/41998449/references?page=2